Position in HLN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$10,487,609
-$484,581 QoQ
Shares Held
1,124,074
+2.5% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#47
of 640 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 15%
Shared 0%
None 85%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Derivatives in HLN
reported options exposure · as of Jun 30, 2026CallValue
$947,928
CallShares
101,600
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026UBS Group AG holds $1,471,514,369 across 82 Drug Manufacturers - Specialty & Generic names. HLN ranks #19 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,643,241 | $261,803,294 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
9,910,822 | $243,905,327 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
220,616 | $119,536,366 | |
| 4 | VTRS |
Viatris Inc
|
6,092,296 | $96,745,659 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
835,494 | $92,689,703 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
2,660,810 | $92,250,281 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
545,937 | $92,012,220 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
2,140,065 | $72,505,400 |
All Filings in HLN
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,487,609 | 1,124,074 | Shares | Defined | 2026-08-13 | |
| 2026-06-30 | $947,928 | 101,600 | Call | Defined | 2026-08-13 | |
| 2026-03-31 | $10,972,190 | 1,096,123 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $10,069,426 | 995,987 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $4,308,441 | 480,317 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $63,452,587 | 6,118,861 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $147,773,648 | 14,360,899 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $64,193,571 | 6,728,886 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $14,310,612 | 1,352,610 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $12,980,266 | 1,571,461 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $15,684,883 | 1,847,454 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $12,657,902 | 1,538,020 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $13,099,915 | 1,572,619 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $13,656,181 | 1,629,616 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $14,440,546 | 1,774,023 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $13,771,744 | 1,721,468 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $10,425,048 | 1,711,831 | Shares | Defined | 2022-11-10 | |
| No filing history on record for this holder in this stock. | ||||||